Sachin Wani
Concepts (596)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Barrett Esophagus | 103 | 2025 | 144 | 32.050 |
Why?
| Esophageal Neoplasms | 76 | 2024 | 293 | 21.270 |
Why?
| Adenocarcinoma | 62 | 2024 | 888 | 10.880 |
Why?
| Cholangiopancreatography, Endoscopic Retrograde | 43 | 2025 | 206 | 10.660 |
Why?
| Esophagoscopy | 54 | 2024 | 195 | 9.890 |
Why?
| Endosonography | 37 | 2024 | 142 | 9.610 |
Why?
| Gastroenterology | 29 | 2025 | 174 | 8.890 |
Why?
| Endoscopy, Gastrointestinal | 42 | 2024 | 217 | 8.290 |
Why?
| Endoscopy, Digestive System | 24 | 2023 | 122 | 7.170 |
Why?
| Precancerous Conditions | 28 | 2023 | 161 | 7.120 |
Why?
| Colonoscopy | 33 | 2025 | 234 | 6.570 |
Why?
| Quality Indicators, Health Care | 19 | 2024 | 296 | 6.570 |
Why?
| Colonic Polyps | 22 | 2025 | 87 | 5.980 |
Why?
| Endoscopic Ultrasound-Guided Fine Needle Aspiration | 19 | 2024 | 55 | 5.320 |
Why?
| Clinical Competence | 28 | 2025 | 1007 | 4.880 |
Why?
| Gastroesophageal Reflux | 19 | 2023 | 230 | 4.740 |
Why?
| Esophagus | 21 | 2021 | 248 | 4.100 |
Why?
| Pancreatic Neoplasms | 23 | 2024 | 873 | 3.560 |
Why?
| Learning Curve | 13 | 2024 | 66 | 3.330 |
Why?
| Endoscopic Mucosal Resection | 11 | 2024 | 22 | 3.080 |
Why?
| Adenoma | 17 | 2023 | 212 | 2.970 |
Why?
| Population Surveillance | 11 | 2021 | 426 | 2.910 |
Why?
| Gastrointestinal Diseases | 9 | 2022 | 196 | 2.840 |
Why?
| Pancreatitis | 15 | 2024 | 128 | 2.740 |
Why?
| Humans | 289 | 2025 | 128020 | 2.590 |
Why?
| Endoscopy | 15 | 2021 | 266 | 2.580 |
Why?
| Biopsy | 23 | 2023 | 1077 | 2.180 |
Why?
| Cholangitis | 6 | 2024 | 20 | 2.040 |
Why?
| Colorectal Neoplasms | 14 | 2023 | 746 | 2.020 |
Why?
| Pancreatic Cyst | 4 | 2020 | 52 | 1.920 |
Why?
| Watchful Waiting | 8 | 2021 | 65 | 1.770 |
Why?
| Stents | 15 | 2024 | 504 | 1.760 |
Why?
| Guideline Adherence | 5 | 2021 | 523 | 1.750 |
Why?
| Catheter Ablation | 8 | 2022 | 333 | 1.720 |
Why?
| Prospective Studies | 45 | 2024 | 7035 | 1.690 |
Why?
| Societies, Medical | 9 | 2024 | 741 | 1.680 |
Why?
| Narrow Band Imaging | 8 | 2022 | 14 | 1.670 |
Why?
| Fellowships and Scholarships | 5 | 2024 | 271 | 1.660 |
Why?
| Sphincterotomy, Endoscopic | 10 | 2024 | 27 | 1.560 |
Why?
| Bile Duct Neoplasms | 4 | 2021 | 99 | 1.530 |
Why?
| Education, Medical, Graduate | 8 | 2024 | 433 | 1.480 |
Why?
| Pancreatic Diseases | 10 | 2020 | 67 | 1.460 |
Why?
| Hyperplasia | 8 | 2024 | 170 | 1.410 |
Why?
| Disease Progression | 20 | 2023 | 2598 | 1.380 |
Why?
| Middle Aged | 92 | 2025 | 30813 | 1.310 |
Why?
| Fiducial Markers | 2 | 2019 | 8 | 1.290 |
Why?
| Aged | 74 | 2025 | 21892 | 1.280 |
Why?
| Pancreas | 10 | 2024 | 304 | 1.270 |
Why?
| Gastrointestinal Neoplasms | 3 | 2024 | 72 | 1.210 |
Why?
| United States | 40 | 2025 | 13785 | 1.190 |
Why?
| Male | 107 | 2025 | 62758 | 1.150 |
Why?
| Registries | 8 | 2022 | 1873 | 1.130 |
Why?
| Ampulla of Vater | 4 | 2023 | 38 | 1.090 |
Why?
| Needles | 5 | 2024 | 56 | 1.090 |
Why?
| Female | 104 | 2025 | 68017 | 1.070 |
Why?
| Choledocholithiasis | 3 | 2023 | 14 | 1.060 |
Why?
| Ablation Techniques | 4 | 2024 | 31 | 1.060 |
Why?
| Benchmarking | 4 | 2022 | 175 | 1.040 |
Why?
| Esophagitis, Peptic | 3 | 2023 | 15 | 1.030 |
Why?
| Esophagectomy | 7 | 2023 | 124 | 1.030 |
Why?
| Catheterization | 9 | 2024 | 171 | 1.020 |
Why?
| Biopsy, Fine-Needle | 4 | 2017 | 66 | 1.010 |
Why?
| Rectum | 2 | 2019 | 169 | 1.010 |
Why?
| Esophageal Achalasia | 3 | 2021 | 28 | 1.000 |
Why?
| Intestinal Polyps | 2 | 2016 | 17 | 0.990 |
Why?
| Digestive System Diseases | 3 | 2015 | 25 | 0.970 |
Why?
| Gastrointestinal Hemorrhage | 5 | 2024 | 120 | 0.960 |
Why?
| Aptitude | 2 | 2015 | 38 | 0.930 |
Why?
| Practice Patterns, Physicians' | 6 | 2021 | 1260 | 0.930 |
Why?
| Biliary Tract Diseases | 5 | 2020 | 36 | 0.930 |
Why?
| Laryngopharyngeal Reflux | 2 | 2021 | 15 | 0.930 |
Why?
| Self-Assessment | 1 | 2025 | 68 | 0.920 |
Why?
| Pepsin A | 2 | 2021 | 19 | 0.920 |
Why?
| Observer Variation | 13 | 2017 | 310 | 0.910 |
Why?
| Self Expandable Metallic Stents | 2 | 2021 | 14 | 0.900 |
Why?
| Margins of Excision | 1 | 2024 | 37 | 0.890 |
Why?
| Lymph Nodes | 4 | 2015 | 465 | 0.880 |
Why?
| Neoplasm Staging | 8 | 2024 | 1288 | 0.860 |
Why?
| Taurine | 1 | 2023 | 40 | 0.860 |
Why?
| Practice Guidelines as Topic | 11 | 2021 | 1482 | 0.850 |
Why?
| Colonic Pseudo-Obstruction | 2 | 2020 | 4 | 0.850 |
Why?
| Pancreatic Ducts | 6 | 2024 | 79 | 0.840 |
Why?
| Intestinal Volvulus | 2 | 2020 | 13 | 0.840 |
Why?
| Time-to-Treatment | 1 | 2024 | 178 | 0.830 |
Why?
| Disease Management | 3 | 2021 | 583 | 0.790 |
Why?
| Treatment Outcome | 28 | 2025 | 10110 | 0.780 |
Why?
| Stomach Diseases | 2 | 2014 | 20 | 0.780 |
Why?
| Incidence | 18 | 2024 | 2614 | 0.770 |
Why?
| Rectal Diseases | 2 | 2019 | 19 | 0.760 |
Why?
| Cholestasis | 3 | 2021 | 228 | 0.760 |
Why?
| Drainage | 7 | 2023 | 165 | 0.750 |
Why?
| Endoscopes | 2 | 2021 | 18 | 0.750 |
Why?
| Teaching Rounds | 1 | 2022 | 68 | 0.740 |
Why?
| Deglutition Disorders | 2 | 2021 | 131 | 0.740 |
Why?
| Neoplasm Recurrence, Local | 6 | 2023 | 955 | 0.730 |
Why?
| Referral and Consultation | 4 | 2024 | 724 | 0.730 |
Why?
| Retrospective Studies | 36 | 2025 | 14404 | 0.720 |
Why?
| Esophageal Sphincter, Lower | 2 | 2021 | 12 | 0.720 |
Why?
| Equipment Reuse | 1 | 2021 | 14 | 0.720 |
Why?
| Esophageal Diseases | 2 | 2014 | 27 | 0.710 |
Why?
| Dilatation | 3 | 2019 | 59 | 0.710 |
Why?
| Pancreatectomy | 3 | 2021 | 241 | 0.710 |
Why?
| Argon Plasma Coagulation | 1 | 2020 | 4 | 0.700 |
Why?
| Sensitivity and Specificity | 19 | 2023 | 1813 | 0.700 |
Why?
| Hemostasis, Endoscopic | 1 | 2020 | 1 | 0.700 |
Why?
| Competency-Based Education | 2 | 2024 | 68 | 0.690 |
Why?
| Gastrointestinal Stromal Tumors | 2 | 2017 | 46 | 0.680 |
Why?
| Heller Myotomy | 1 | 2019 | 1 | 0.670 |
Why?
| Acetylcholine Release Inhibitors | 1 | 2019 | 3 | 0.670 |
Why?
| Sigmoid Diseases | 1 | 2019 | 10 | 0.670 |
Why?
| Esophageal Motility Disorders | 1 | 2020 | 26 | 0.660 |
Why?
| SEER Program | 4 | 2020 | 206 | 0.660 |
Why?
| Early Detection of Cancer | 12 | 2022 | 369 | 0.660 |
Why?
| Cholinesterase Inhibitors | 1 | 2019 | 27 | 0.660 |
Why?
| Bile Ducts | 3 | 2014 | 67 | 0.650 |
Why?
| Proctoscopy | 1 | 2019 | 5 | 0.650 |
Why?
| Delphi Technique | 5 | 2024 | 221 | 0.650 |
Why?
| Carcinoma | 3 | 2021 | 215 | 0.640 |
Why?
| Conservative Treatment | 1 | 2019 | 33 | 0.640 |
Why?
| Botulinum Toxins | 1 | 2019 | 38 | 0.640 |
Why?
| Medical Overuse | 1 | 2019 | 30 | 0.640 |
Why?
| Quality of Health Care | 2 | 2021 | 605 | 0.630 |
Why?
| Radiotherapy, Image-Guided | 1 | 2019 | 33 | 0.630 |
Why?
| Decompression, Surgical | 1 | 2019 | 99 | 0.630 |
Why?
| Racism | 1 | 2021 | 129 | 0.620 |
Why?
| Stomach Neoplasms | 4 | 2024 | 97 | 0.610 |
Why?
| Risk Factors | 21 | 2024 | 9696 | 0.610 |
Why?
| Acute Disease | 8 | 2024 | 961 | 0.610 |
Why?
| Colonic Neoplasms | 7 | 2022 | 242 | 0.610 |
Why?
| Family Health | 1 | 2019 | 194 | 0.590 |
Why?
| Radiation Injuries | 1 | 2019 | 135 | 0.590 |
Why?
| Conflict of Interest | 1 | 2020 | 123 | 0.590 |
Why?
| Intestinal Perforation | 2 | 2016 | 44 | 0.580 |
Why?
| Adult | 46 | 2025 | 35177 | 0.570 |
Why?
| Pharmaceutical Preparations | 1 | 2020 | 168 | 0.570 |
Why?
| Prosthesis Implantation | 1 | 2019 | 145 | 0.570 |
Why?
| Cytological Techniques | 1 | 2017 | 26 | 0.560 |
Why?
| Time Factors | 13 | 2024 | 6479 | 0.550 |
Why?
| Metaplasia | 10 | 2023 | 54 | 0.540 |
Why?
| Cathartics | 1 | 2016 | 15 | 0.530 |
Why?
| Quality Assurance, Health Care | 1 | 2019 | 315 | 0.530 |
Why?
| Documentation | 2 | 2023 | 181 | 0.530 |
Why?
| Conscious Sedation | 2 | 2020 | 84 | 0.530 |
Why?
| Carcinoembryonic Antigen | 2 | 2018 | 41 | 0.520 |
Why?
| Diagnostic Tests, Routine | 1 | 2017 | 101 | 0.520 |
Why?
| Specimen Handling | 1 | 2017 | 163 | 0.520 |
Why?
| Diarrhea | 3 | 2019 | 178 | 0.520 |
Why?
| Hypnotics and Sedatives | 2 | 2020 | 156 | 0.520 |
Why?
| Cohort Studies | 9 | 2023 | 5378 | 0.520 |
Why?
| Hospitals | 1 | 2021 | 631 | 0.520 |
Why?
| Aged, 80 and over | 21 | 2025 | 7029 | 0.500 |
Why?
| Neoplasms, Cystic, Mucinous, and Serous | 1 | 2016 | 25 | 0.500 |
Why?
| Adenomatous Polyps | 1 | 2015 | 10 | 0.500 |
Why?
| Quality Improvement | 2 | 2021 | 1093 | 0.500 |
Why?
| Cystadenoma, Mucinous | 1 | 2015 | 13 | 0.490 |
Why?
| Predictive Value of Tests | 17 | 2019 | 1934 | 0.490 |
Why?
| Cystadenocarcinoma, Mucinous | 1 | 2015 | 14 | 0.490 |
Why?
| Carcinoma, Squamous Cell | 4 | 2014 | 620 | 0.490 |
Why?
| Pathology, Clinical | 1 | 2015 | 36 | 0.480 |
Why?
| Ultrasonography, Interventional | 2 | 2019 | 128 | 0.480 |
Why?
| Neoplasms | 3 | 2020 | 2460 | 0.480 |
Why?
| Jaundice, Obstructive | 1 | 2014 | 2 | 0.480 |
Why?
| Duodenal Diseases | 1 | 2014 | 8 | 0.470 |
Why?
| Aftercare | 4 | 2023 | 206 | 0.470 |
Why?
| Hemorrhage | 4 | 2020 | 643 | 0.460 |
Why?
| Pancreaticoduodenectomy | 1 | 2016 | 158 | 0.460 |
Why?
| Curriculum | 2 | 2024 | 909 | 0.460 |
Why?
| Foreign-Body Migration | 1 | 2014 | 35 | 0.450 |
Why?
| Duodenum | 1 | 2014 | 71 | 0.450 |
Why?
| Intestinal Mucosa | 4 | 2015 | 575 | 0.450 |
Why?
| Mucous Membrane | 9 | 2015 | 120 | 0.450 |
Why?
| Colectomy | 1 | 2015 | 93 | 0.450 |
Why?
| Indomethacin | 2 | 2024 | 77 | 0.450 |
Why?
| Recurrence | 4 | 2024 | 993 | 0.440 |
Why?
| Internship and Residency | 3 | 2021 | 1043 | 0.440 |
Why?
| Advisory Committees | 5 | 2014 | 214 | 0.440 |
Why?
| Cholecystectomy | 3 | 2019 | 59 | 0.440 |
Why?
| Delivery of Health Care | 1 | 2021 | 888 | 0.440 |
Why?
| Precision Medicine | 1 | 2017 | 384 | 0.430 |
Why?
| Multimodal Imaging | 1 | 2014 | 109 | 0.430 |
Why?
| Risk Assessment | 10 | 2020 | 3223 | 0.430 |
Why?
| Tomography, X-Ray Computed | 6 | 2020 | 2509 | 0.430 |
Why?
| Educational Measurement | 4 | 2025 | 257 | 0.420 |
Why?
| Polyps | 1 | 2013 | 11 | 0.420 |
Why?
| Enteral Nutrition | 3 | 2021 | 186 | 0.410 |
Why?
| Positron-Emission Tomography | 1 | 2014 | 283 | 0.410 |
Why?
| Peutz-Jeghers Syndrome | 1 | 2012 | 9 | 0.410 |
Why?
| Education, Medical, Continuing | 3 | 2022 | 121 | 0.410 |
Why?
| Bile Ducts, Intrahepatic | 1 | 2013 | 65 | 0.410 |
Why?
| Reproducibility of Results | 16 | 2023 | 3009 | 0.410 |
Why?
| Health Care Costs | 1 | 2015 | 366 | 0.400 |
Why?
| Cholangiocarcinoma | 1 | 2013 | 77 | 0.390 |
Why?
| Cholecystitis | 3 | 2024 | 23 | 0.390 |
Why?
| Gastroenterologists | 2 | 2022 | 18 | 0.390 |
Why?
| Logistic Models | 8 | 2024 | 1975 | 0.390 |
Why?
| Pandemics | 6 | 2023 | 1473 | 0.390 |
Why?
| Multivariate Analysis | 7 | 2021 | 1492 | 0.380 |
Why?
| Liver Neoplasms | 3 | 2023 | 633 | 0.380 |
Why?
| Postoperative Complications | 5 | 2024 | 2456 | 0.370 |
Why?
| Manometry | 3 | 2021 | 90 | 0.370 |
Why?
| Neuroendocrine Tumors | 3 | 2018 | 97 | 0.370 |
Why?
| Propofol | 1 | 2011 | 52 | 0.370 |
Why?
| Laparoscopy | 1 | 2015 | 450 | 0.360 |
Why?
| Pneumonia, Viral | 3 | 2020 | 337 | 0.360 |
Why?
| Coronavirus Infections | 3 | 2020 | 333 | 0.360 |
Why?
| Sex Factors | 5 | 2021 | 1942 | 0.360 |
Why?
| Myotomy | 2 | 2021 | 11 | 0.360 |
Why?
| Video Recording | 7 | 2019 | 161 | 0.360 |
Why?
| Consensus | 4 | 2024 | 607 | 0.350 |
Why?
| Hypotension | 1 | 2011 | 115 | 0.350 |
Why?
| Evidence-Based Medicine | 6 | 2024 | 709 | 0.350 |
Why?
| Pathology, Surgical | 1 | 2010 | 8 | 0.340 |
Why?
| Duodenal Neoplasms | 2 | 2023 | 21 | 0.340 |
Why?
| Education, Medical | 1 | 2013 | 243 | 0.330 |
Why?
| Diagnostic Techniques, Digestive System | 2 | 2019 | 12 | 0.330 |
Why?
| Informed Consent | 3 | 2022 | 168 | 0.320 |
Why?
| Irritable Bowel Syndrome | 2 | 2019 | 28 | 0.320 |
Why?
| Hernia, Hiatal | 4 | 2021 | 32 | 0.320 |
Why?
| Wandering Spleen | 1 | 2008 | 2 | 0.310 |
Why?
| Odds Ratio | 4 | 2018 | 1018 | 0.310 |
Why?
| Survival Rate | 3 | 2021 | 1870 | 0.310 |
Why?
| Histocytochemistry | 4 | 2013 | 82 | 0.300 |
Why?
| Computer-Assisted Instruction | 4 | 2024 | 59 | 0.300 |
Why?
| Image Enhancement | 6 | 2018 | 163 | 0.300 |
Why?
| Surgeons | 2 | 2022 | 259 | 0.300 |
Why?
| Tertiary Care Centers | 4 | 2016 | 146 | 0.290 |
Why?
| Microscopy, Confocal | 5 | 2020 | 307 | 0.280 |
Why?
| Decision Trees | 2 | 2019 | 90 | 0.280 |
Why?
| Proton Pump Inhibitors | 3 | 2022 | 98 | 0.280 |
Why?
| Mass Screening | 5 | 2022 | 1145 | 0.280 |
Why?
| Liver Transplantation | 1 | 2014 | 799 | 0.270 |
Why?
| Malignant Catarrh | 1 | 2006 | 1 | 0.270 |
Why?
| Goats | 1 | 2006 | 25 | 0.270 |
Why?
| Fluid Therapy | 2 | 2018 | 134 | 0.270 |
Why?
| Sphincter of Oddi | 3 | 2024 | 5 | 0.270 |
Why?
| Herpesviridae | 1 | 2006 | 22 | 0.270 |
Why?
| Age Factors | 5 | 2020 | 3100 | 0.270 |
Why?
| Cholangiopancreatography, Magnetic Resonance | 2 | 2019 | 17 | 0.260 |
Why?
| Obesity | 4 | 2019 | 2859 | 0.260 |
Why?
| Picolinic Acids | 1 | 2006 | 4 | 0.260 |
Why?
| Prevalence | 7 | 2023 | 2541 | 0.260 |
Why?
| Carrier State | 1 | 2006 | 60 | 0.260 |
Why?
| Kidney Tubular Necrosis, Acute | 1 | 2006 | 26 | 0.250 |
Why?
| Natural Orifice Endoscopic Surgery | 3 | 2021 | 29 | 0.250 |
Why?
| Follow-Up Studies | 10 | 2015 | 4853 | 0.250 |
Why?
| Feasibility Studies | 6 | 2024 | 860 | 0.240 |
Why?
| Decision Support Techniques | 3 | 2019 | 396 | 0.240 |
Why?
| Carcinoma, Pancreatic Ductal | 3 | 2017 | 265 | 0.240 |
Why?
| Singapore | 1 | 2025 | 20 | 0.240 |
Why?
| Sphincter of Oddi Dysfunction | 1 | 2024 | 1 | 0.240 |
Why?
| Diagnosis, Differential | 6 | 2019 | 1408 | 0.240 |
Why?
| Cattle Diseases | 1 | 2005 | 21 | 0.240 |
Why?
| Constriction, Pathologic | 5 | 2020 | 228 | 0.230 |
Why?
| Anti-Inflammatory Agents, Non-Steroidal | 2 | 2024 | 332 | 0.230 |
Why?
| Heartburn | 2 | 2021 | 12 | 0.230 |
Why?
| Hypoxia | 1 | 2011 | 1034 | 0.230 |
Why?
| DNA, Viral | 1 | 2006 | 348 | 0.230 |
Why?
| Escherichia coli Infections | 1 | 2005 | 105 | 0.230 |
Why?
| Program Evaluation | 2 | 2020 | 872 | 0.220 |
Why?
| Sheep | 1 | 2006 | 828 | 0.220 |
Why?
| Bile Duct Diseases | 2 | 2014 | 14 | 0.220 |
Why?
| Common Bile Duct Neoplasms | 1 | 2023 | 27 | 0.210 |
Why?
| Postoperative Hemorrhage | 1 | 2024 | 86 | 0.210 |
Why?
| Kaplan-Meier Estimate | 3 | 2020 | 851 | 0.210 |
Why?
| Genetic Predisposition to Disease | 2 | 2022 | 2261 | 0.210 |
Why?
| Ergonomics | 1 | 2023 | 23 | 0.210 |
Why?
| Pancreatitis, Acute Necrotizing | 1 | 2023 | 12 | 0.210 |
Why?
| Cytodiagnosis | 2 | 2020 | 32 | 0.210 |
Why?
| Cholelithiasis | 1 | 2023 | 36 | 0.210 |
Why?
| Microsurgery | 1 | 2023 | 70 | 0.200 |
Why?
| Biomedical Research | 2 | 2020 | 632 | 0.200 |
Why?
| Epstein-Barr Virus Infections | 1 | 2024 | 93 | 0.200 |
Why?
| Carcinoid Tumor | 1 | 2022 | 24 | 0.200 |
Why?
| Gastrointestinal Tract | 1 | 2025 | 182 | 0.200 |
Why?
| Medicare | 2 | 2021 | 715 | 0.200 |
Why?
| Appendiceal Neoplasms | 1 | 2022 | 26 | 0.200 |
Why?
| Fluorouracil | 1 | 2023 | 197 | 0.200 |
Why?
| Forecasting | 1 | 2024 | 355 | 0.200 |
Why?
| Gastrectomy | 2 | 2023 | 99 | 0.200 |
Why?
| Surgical Instruments | 3 | 2022 | 50 | 0.200 |
Why?
| Weight Loss | 2 | 2021 | 725 | 0.190 |
Why?
| Health Care Surveys | 3 | 2020 | 556 | 0.190 |
Why?
| Diverticulum, Esophageal | 1 | 2021 | 3 | 0.190 |
Why?
| Disease Outbreaks | 1 | 2005 | 339 | 0.190 |
Why?
| Lithotripsy | 2 | 2019 | 43 | 0.190 |
Why?
| Esophageal Sphincter, Upper | 1 | 2021 | 5 | 0.190 |
Why?
| Dietary Supplements | 1 | 2006 | 531 | 0.190 |
Why?
| Aspirin | 1 | 2025 | 377 | 0.190 |
Why?
| Proton Pumps | 1 | 2021 | 8 | 0.190 |
Why?
| Biopsy, Needle | 2 | 2020 | 187 | 0.190 |
Why?
| Professional Practice Location | 2 | 2019 | 29 | 0.190 |
Why?
| Pancreatic Pseudocyst | 2 | 2018 | 13 | 0.180 |
Why?
| Single-Blind Method | 5 | 2014 | 267 | 0.180 |
Why?
| Endoscopes, Gastrointestinal | 1 | 2021 | 14 | 0.180 |
Why?
| Trefoil Factor-3 | 1 | 2020 | 5 | 0.180 |
Why?
| Internationality | 2 | 2020 | 149 | 0.180 |
Why?
| Escherichia coli | 1 | 2005 | 766 | 0.180 |
Why?
| Gastric Outlet Obstruction | 1 | 2020 | 9 | 0.180 |
Why?
| Formative Feedback | 2 | 2024 | 26 | 0.180 |
Why?
| Digestive System Surgical Procedures | 1 | 2021 | 96 | 0.180 |
Why?
| Oral Submucous Fibrosis | 1 | 2020 | 2 | 0.180 |
Why?
| Midazolam | 1 | 2020 | 48 | 0.180 |
Why?
| Equipment Contamination | 1 | 2021 | 54 | 0.180 |
Why?
| Betacoronavirus | 2 | 2020 | 247 | 0.170 |
Why?
| Radiography, Abdominal | 2 | 2012 | 44 | 0.170 |
Why?
| Stomach | 2 | 2012 | 109 | 0.170 |
Why?
| Varicose Veins | 1 | 2020 | 17 | 0.170 |
Why?
| Laparotomy | 2 | 2012 | 106 | 0.170 |
Why?
| Cost-Benefit Analysis | 3 | 2015 | 567 | 0.170 |
Why?
| United Arab Emirates | 1 | 2020 | 7 | 0.170 |
Why?
| Emergencies | 1 | 2021 | 154 | 0.170 |
Why?
| Esophageal and Gastric Varices | 1 | 2020 | 37 | 0.170 |
Why?
| Morbidity | 1 | 2021 | 301 | 0.170 |
Why?
| Neostigmine | 1 | 2019 | 7 | 0.170 |
Why?
| Body Fluids | 1 | 2020 | 62 | 0.170 |
Why?
| Cecum | 1 | 2019 | 32 | 0.170 |
Why?
| Adenomatous Polyposis Coli | 1 | 2020 | 33 | 0.170 |
Why?
| Perception | 1 | 2022 | 336 | 0.170 |
Why?
| Colostomy | 1 | 2019 | 26 | 0.170 |
Why?
| Disease Transmission, Infectious | 1 | 2020 | 55 | 0.160 |
Why?
| Survival Analysis | 2 | 2015 | 1262 | 0.160 |
Why?
| Pancreatitis, Chronic | 2 | 2019 | 51 | 0.160 |
Why?
| Accreditation | 1 | 2020 | 79 | 0.160 |
Why?
| Dissection | 2 | 2020 | 51 | 0.160 |
Why?
| Research Design | 2 | 2020 | 1034 | 0.160 |
Why?
| Saliva | 1 | 2021 | 207 | 0.160 |
Why?
| Injections, Intramuscular | 1 | 2019 | 115 | 0.160 |
Why?
| ROC Curve | 4 | 2015 | 500 | 0.160 |
Why?
| Disinfection | 1 | 2021 | 115 | 0.160 |
Why?
| Mirizzi Syndrome | 1 | 2019 | 1 | 0.160 |
Why?
| India | 3 | 2018 | 170 | 0.160 |
Why?
| Urinary Calculi | 1 | 2019 | 11 | 0.160 |
Why?
| Obesity, Morbid | 1 | 2023 | 239 | 0.160 |
Why?
| Ascites | 1 | 2019 | 44 | 0.160 |
Why?
| Anastomotic Leak | 1 | 2019 | 38 | 0.160 |
Why?
| Infection Control | 1 | 2020 | 136 | 0.160 |
Why?
| In Situ Hybridization, Fluorescence | 1 | 2020 | 313 | 0.160 |
Why?
| Chronic Disease | 3 | 2019 | 1690 | 0.160 |
Why?
| Feedback | 1 | 2019 | 159 | 0.160 |
Why?
| Mastitis, Bovine | 1 | 2018 | 3 | 0.150 |
Why?
| Phage Therapy | 1 | 2018 | 10 | 0.150 |
Why?
| Esophageal Mucosa | 1 | 2018 | 19 | 0.150 |
Why?
| Fluoroscopy | 1 | 2019 | 156 | 0.150 |
Why?
| Plastics | 2 | 2018 | 47 | 0.150 |
Why?
| Health Status Disparities | 1 | 2021 | 254 | 0.150 |
Why?
| Esophagogastric Junction | 3 | 2021 | 50 | 0.150 |
Why?
| Clinical Protocols | 1 | 2019 | 253 | 0.150 |
Why?
| Mortality | 1 | 2020 | 306 | 0.150 |
Why?
| Gallstones | 1 | 2018 | 31 | 0.150 |
Why?
| Cystadenoma, Serous | 1 | 2018 | 17 | 0.150 |
Why?
| Colonoscopes | 3 | 2014 | 5 | 0.150 |
Why?
| Quality-Adjusted Life Years | 2 | 2015 | 106 | 0.140 |
Why?
| Markov Chains | 2 | 2015 | 116 | 0.140 |
Why?
| Case-Control Studies | 4 | 2021 | 3324 | 0.140 |
Why?
| Prognosis | 3 | 2017 | 3766 | 0.140 |
Why?
| Anti-Bacterial Agents | 2 | 2018 | 1689 | 0.140 |
Why?
| Diagnostic Techniques and Procedures | 1 | 2017 | 17 | 0.140 |
Why?
| Reference Standards | 1 | 2018 | 168 | 0.140 |
Why?
| Palliative Care | 2 | 2021 | 714 | 0.140 |
Why?
| Aneurysm, False | 1 | 2018 | 48 | 0.140 |
Why?
| Osteoclasts | 1 | 2017 | 42 | 0.140 |
Why?
| Artificial Intelligence | 1 | 2020 | 244 | 0.140 |
Why?
| Cardia | 2 | 2007 | 2 | 0.140 |
Why?
| Medical Staff Privileges | 1 | 2017 | 5 | 0.140 |
Why?
| Education | 1 | 2017 | 100 | 0.140 |
Why?
| Optical Imaging | 2 | 2018 | 56 | 0.140 |
Why?
| Severity of Illness Index | 6 | 2021 | 2703 | 0.140 |
Why?
| Iatrogenic Disease | 1 | 2017 | 54 | 0.140 |
Why?
| Bacteriophages | 1 | 2018 | 92 | 0.140 |
Why?
| Research | 1 | 2020 | 408 | 0.140 |
Why?
| Credentialing | 1 | 2017 | 16 | 0.140 |
Why?
| Cattle | 3 | 2018 | 962 | 0.130 |
Why?
| MicroRNAs | 2 | 2015 | 674 | 0.130 |
Why?
| Upper Gastrointestinal Tract | 1 | 2016 | 5 | 0.130 |
Why?
| Immunoassay | 1 | 2017 | 103 | 0.130 |
Why?
| Patient Discharge | 1 | 2023 | 850 | 0.130 |
Why?
| Leiomyoma | 1 | 2017 | 74 | 0.130 |
Why?
| Bariatric Surgery | 1 | 2019 | 192 | 0.130 |
Why?
| Chemoprevention | 2 | 2014 | 90 | 0.120 |
Why?
| Global Health | 1 | 2018 | 327 | 0.120 |
Why?
| Adenocarcinoma, Mucinous | 1 | 2016 | 75 | 0.120 |
Why?
| Antibiotic Prophylaxis | 1 | 2016 | 101 | 0.120 |
Why?
| Analysis of Variance | 1 | 2018 | 1266 | 0.120 |
Why?
| Surveys and Questionnaires | 8 | 2024 | 5353 | 0.120 |
Why?
| Physicians | 1 | 2024 | 858 | 0.120 |
Why?
| Teaching | 1 | 2017 | 210 | 0.120 |
Why?
| Neoplasms, Multiple Primary | 1 | 2015 | 54 | 0.120 |
Why?
| Metals | 3 | 2023 | 126 | 0.120 |
Why?
| Costs and Cost Analysis | 1 | 2015 | 200 | 0.120 |
Why?
| Intestinal Fistula | 1 | 2014 | 15 | 0.120 |
Why?
| Administration, Rectal | 2 | 2024 | 11 | 0.110 |
Why?
| Task Performance and Analysis | 1 | 2015 | 173 | 0.110 |
Why?
| Colorectal Surgery | 1 | 2014 | 22 | 0.110 |
Why?
| Cryosurgery | 1 | 2015 | 56 | 0.110 |
Why?
| Health Status | 1 | 2019 | 747 | 0.110 |
Why?
| Goblet Cells | 1 | 2013 | 18 | 0.110 |
Why?
| Combined Modality Therapy | 2 | 2015 | 1199 | 0.110 |
Why?
| Prosthesis Failure | 1 | 2014 | 112 | 0.110 |
Why?
| Suture Techniques | 1 | 2014 | 117 | 0.110 |
Why?
| Staphylococcal Infections | 1 | 2018 | 386 | 0.110 |
Why?
| Primary Health Care | 2 | 2022 | 1639 | 0.110 |
Why?
| Bone Density | 1 | 2017 | 474 | 0.110 |
Why?
| Propensity Score | 1 | 2015 | 264 | 0.110 |
Why?
| Animals, Newborn | 2 | 2006 | 801 | 0.110 |
Why?
| Patient Participation | 1 | 2017 | 409 | 0.110 |
Why?
| Biomarkers | 5 | 2025 | 3874 | 0.100 |
Why?
| Light | 2 | 2013 | 353 | 0.100 |
Why?
| Multidetector Computed Tomography | 1 | 2013 | 32 | 0.100 |
Why?
| Jejunum | 1 | 2012 | 30 | 0.100 |
Why?
| Polymerase Chain Reaction | 2 | 2006 | 1020 | 0.100 |
Why?
| Equipment Design | 3 | 2021 | 515 | 0.100 |
Why?
| Mediastinum | 1 | 2012 | 23 | 0.100 |
Why?
| Young Adult | 8 | 2025 | 12282 | 0.100 |
Why?
| Carcinoma, Hepatocellular | 1 | 2014 | 270 | 0.100 |
Why?
| Decision Making | 3 | 2023 | 846 | 0.100 |
Why?
| Inflammatory Bowel Diseases | 1 | 2016 | 311 | 0.100 |
Why?
| Peptides | 1 | 2017 | 910 | 0.100 |
Why?
| Anesthetics, Intravenous | 1 | 2011 | 38 | 0.090 |
Why?
| Abdomen | 1 | 2012 | 116 | 0.090 |
Why?
| Injections, Intravenous | 1 | 2011 | 197 | 0.090 |
Why?
| Proportional Hazards Models | 1 | 2014 | 1194 | 0.090 |
Why?
| Patient Selection | 1 | 2015 | 658 | 0.090 |
Why?
| Adrenal Glands | 1 | 2011 | 70 | 0.090 |
Why?
| Guidelines as Topic | 1 | 2012 | 260 | 0.090 |
Why?
| Proteomics | 1 | 2017 | 1008 | 0.090 |
Why?
| Intestines | 1 | 2013 | 344 | 0.090 |
Why?
| Biomarkers, Tumor | 1 | 2017 | 1175 | 0.090 |
Why?
| Adolescent | 8 | 2025 | 20158 | 0.080 |
Why?
| Veterans | 1 | 2021 | 1397 | 0.080 |
Why?
| Esophagitis | 2 | 2007 | 67 | 0.080 |
Why?
| Software | 1 | 2014 | 606 | 0.080 |
Why?
| Esophageal pH Monitoring | 1 | 2009 | 23 | 0.080 |
Why?
| Body Mass Index | 3 | 2013 | 2260 | 0.080 |
Why?
| North America | 2 | 2020 | 289 | 0.080 |
Why?
| Gastric Acid | 1 | 2009 | 14 | 0.080 |
Why?
| Antacids | 1 | 2009 | 14 | 0.080 |
Why?
| Remission Induction | 1 | 2009 | 267 | 0.070 |
Why?
| National Institute of Diabetes and Digestive and Kidney Diseases (U.S.) | 2 | 2017 | 9 | 0.070 |
Why?
| Patient Care Planning | 1 | 2009 | 148 | 0.070 |
Why?
| Hematoporphyrin Photoradiation | 1 | 2007 | 1 | 0.070 |
Why?
| Colonography, Computed Tomographic | 1 | 2007 | 6 | 0.070 |
Why?
| Patient Acceptance of Health Care | 1 | 2014 | 756 | 0.070 |
Why?
| Gastric Fundus | 1 | 2007 | 3 | 0.070 |
Why?
| Capsule Endoscopy | 1 | 2007 | 18 | 0.070 |
Why?
| Clinical Trials as Topic | 2 | 2015 | 997 | 0.070 |
Why?
| Plasmapheresis | 1 | 2006 | 22 | 0.060 |
Why?
| Gastritis | 1 | 2007 | 96 | 0.060 |
Why?
| Image Interpretation, Computer-Assisted | 1 | 2007 | 253 | 0.060 |
Why?
| Dairying | 1 | 2005 | 7 | 0.060 |
Why?
| CDX2 Transcription Factor | 1 | 2025 | 1 | 0.060 |
Why?
| Seasons | 1 | 2006 | 498 | 0.060 |
Why?
| Virulence | 1 | 2005 | 252 | 0.060 |
Why?
| Image-Guided Biopsy | 2 | 2015 | 37 | 0.060 |
Why?
| DNA Primers | 1 | 2005 | 509 | 0.050 |
Why?
| Glypicans | 1 | 2023 | 9 | 0.050 |
Why?
| Enzyme Inhibitors | 1 | 2007 | 809 | 0.050 |
Why?
| DNA, Bacterial | 1 | 2005 | 323 | 0.050 |
Why?
| Hospitalization | 2 | 2023 | 2057 | 0.050 |
Why?
| Herpesvirus 4, Human | 1 | 2024 | 152 | 0.050 |
Why?
| United Kingdom | 1 | 2023 | 258 | 0.050 |
Why?
| Tumor Burden | 2 | 2015 | 283 | 0.050 |
Why?
| Liver | 1 | 2011 | 1826 | 0.050 |
Why?
| Anti-Inflammatory Agents | 1 | 2006 | 467 | 0.050 |
Why?
| Necrosis | 1 | 2023 | 228 | 0.050 |
Why?
| Appendectomy | 1 | 2022 | 76 | 0.050 |
Why?
| Renal Dialysis | 1 | 2006 | 420 | 0.050 |
Why?
| Feces | 1 | 2005 | 435 | 0.050 |
Why?
| B7-H1 Antigen | 1 | 2024 | 189 | 0.050 |
Why?
| Blood Transfusion | 1 | 2024 | 291 | 0.050 |
Why?
| Technology | 1 | 2022 | 84 | 0.050 |
Why?
| Colonic Diseases | 2 | 2014 | 32 | 0.050 |
Why?
| Clinical Decision-Making | 1 | 2024 | 302 | 0.050 |
Why?
| Induction Chemotherapy | 1 | 2021 | 70 | 0.040 |
Why?
| Lifting | 1 | 2020 | 4 | 0.040 |
Why?
| Cross-Sectional Studies | 2 | 2022 | 5034 | 0.040 |
Why?
| Infectious Disease Transmission, Professional-to-Patient | 1 | 2020 | 5 | 0.040 |
Why?
| Meta-Analysis as Topic | 1 | 2021 | 169 | 0.040 |
Why?
| Animals | 4 | 2018 | 34487 | 0.040 |
Why?
| Infectious Disease Transmission, Patient-to-Professional | 1 | 2020 | 18 | 0.040 |
Why?
| Double-Blind Method | 1 | 2025 | 1852 | 0.040 |
Why?
| Cough | 1 | 2021 | 115 | 0.040 |
Why?
| Granuloma | 1 | 2020 | 83 | 0.040 |
Why?
| Statistics, Nonparametric | 2 | 2012 | 419 | 0.040 |
Why?
| Personal Protective Equipment | 1 | 2020 | 50 | 0.040 |
Why?
| Symptom Assessment | 1 | 2021 | 124 | 0.040 |
Why?
| Chemoradiotherapy | 1 | 2021 | 209 | 0.040 |
Why?
| Pilot Projects | 3 | 2011 | 1559 | 0.040 |
Why?
| Rural Population | 1 | 2023 | 511 | 0.040 |
Why?
| Cross-Over Studies | 2 | 2012 | 507 | 0.040 |
Why?
| Physician-Patient Relations | 1 | 2024 | 529 | 0.040 |
Why?
| Myoviridae | 1 | 2018 | 1 | 0.040 |
Why?
| Podoviridae | 1 | 2018 | 1 | 0.040 |
Why?
| Age of Onset | 1 | 2020 | 490 | 0.040 |
Why?
| Drug Resistance, Neoplasm | 1 | 2023 | 744 | 0.040 |
Why?
| Coloring Agents | 1 | 2018 | 75 | 0.040 |
Why?
| Neoadjuvant Therapy | 1 | 2021 | 381 | 0.040 |
Why?
| Randomized Controlled Trials as Topic | 1 | 2024 | 1356 | 0.040 |
Why?
| Microscopy, Electron, Transmission | 1 | 2018 | 142 | 0.040 |
Why?
| Liver Cirrhosis | 1 | 2020 | 279 | 0.040 |
Why?
| Electrophoresis, Polyacrylamide Gel | 1 | 2018 | 328 | 0.040 |
Why?
| Cyst Fluid | 1 | 2018 | 26 | 0.040 |
Why?
| Communication | 1 | 2024 | 838 | 0.040 |
Why?
| Abdominal Pain | 1 | 2019 | 144 | 0.040 |
Why?
| Cholecystectomy, Laparoscopic | 1 | 2018 | 51 | 0.040 |
Why?
| Genome, Viral | 1 | 2018 | 127 | 0.040 |
Why?
| Whole Genome Sequencing | 1 | 2018 | 130 | 0.040 |
Why?
| User-Computer Interface | 1 | 2018 | 147 | 0.040 |
Why?
| Hospitals, University | 1 | 2018 | 176 | 0.040 |
Why?
| Longitudinal Studies | 1 | 2024 | 2706 | 0.030 |
Why?
| RNA, Messenger | 1 | 2025 | 2669 | 0.030 |
Why?
| Review Literature as Topic | 1 | 2017 | 66 | 0.030 |
Why?
| Granular Cell Tumor | 1 | 2017 | 7 | 0.030 |
Why?
| Cancer Pain | 1 | 2017 | 26 | 0.030 |
Why?
| Lipoma | 1 | 2017 | 16 | 0.030 |
Why?
| Patient Reported Outcome Measures | 1 | 2020 | 368 | 0.030 |
Why?
| Choristoma | 1 | 2017 | 21 | 0.030 |
Why?
| Quality of Life | 1 | 2009 | 2672 | 0.030 |
Why?
| Genetic Testing | 1 | 2020 | 428 | 0.030 |
Why?
| Choledochal Cyst | 1 | 2016 | 16 | 0.030 |
Why?
| Gastroscopes | 1 | 2016 | 3 | 0.030 |
Why?
| Biliary Tract Neoplasms | 1 | 2016 | 25 | 0.030 |
Why?
| Nerve Block | 1 | 2017 | 65 | 0.030 |
Why?
| Duodenoscopes | 1 | 2016 | 7 | 0.030 |
Why?
| Embolism, Air | 1 | 2016 | 13 | 0.030 |
Why?
| Exons | 1 | 2017 | 338 | 0.030 |
Why?
| Viral Proteins | 1 | 2018 | 321 | 0.030 |
Why?
| Cholangitis, Sclerosing | 1 | 2016 | 70 | 0.030 |
Why?
| Cell Proliferation | 1 | 2023 | 2337 | 0.030 |
Why?
| Cell Line, Tumor | 1 | 2023 | 3168 | 0.030 |
Why?
| Child, Preschool | 2 | 2022 | 10378 | 0.030 |
Why?
| Algorithms | 2 | 2017 | 1609 | 0.030 |
Why?
| HEK293 Cells | 1 | 2017 | 681 | 0.030 |
Why?
| Child | 3 | 2021 | 20636 | 0.030 |
Why?
| Electronic Health Records | 1 | 2022 | 973 | 0.030 |
Why?
| Bone and Bones | 1 | 2017 | 298 | 0.030 |
Why?
| Healthcare Disparities | 1 | 2021 | 579 | 0.030 |
Why?
| Intracellular Signaling Peptides and Proteins | 1 | 2017 | 431 | 0.030 |
Why?
| Apoptosis | 1 | 2023 | 2425 | 0.030 |
Why?
| Equipment Failure | 1 | 2014 | 107 | 0.030 |
Why?
| Proteome | 1 | 2018 | 430 | 0.030 |
Why?
| Autoimmune Diseases | 1 | 2017 | 423 | 0.030 |
Why?
| Pathology | 1 | 2013 | 22 | 0.030 |
Why?
| Health Status Indicators | 1 | 2014 | 166 | 0.030 |
Why?
| Community Health Centers | 1 | 2013 | 57 | 0.030 |
Why?
| Pain | 1 | 2019 | 748 | 0.030 |
Why?
| Community Health Services | 1 | 2014 | 226 | 0.030 |
Why?
| Color | 1 | 2013 | 71 | 0.030 |
Why?
| Phenotype | 1 | 2021 | 3039 | 0.030 |
Why?
| Databases, Factual | 1 | 2018 | 1264 | 0.020 |
Why?
| Neoplasm Grading | 1 | 2013 | 283 | 0.020 |
Why?
| Adenoma, Villous | 1 | 2012 | 2 | 0.020 |
Why?
| Gastroscopy | 1 | 2011 | 18 | 0.020 |
Why?
| Sentinel Surveillance | 1 | 2011 | 40 | 0.020 |
Why?
| Digestive System Neoplasms | 1 | 2011 | 8 | 0.020 |
Why?
| Confidence Intervals | 1 | 2012 | 316 | 0.020 |
Why?
| Microarray Analysis | 1 | 2011 | 120 | 0.020 |
Why?
| Mice, Knockout | 1 | 2017 | 2757 | 0.020 |
Why?
| Academic Medical Centers | 1 | 2013 | 478 | 0.020 |
Why?
| Risk | 1 | 2013 | 850 | 0.020 |
Why?
| Life Style | 1 | 2013 | 459 | 0.020 |
Why?
| Genetic Markers | 1 | 2011 | 338 | 0.020 |
Why?
| Cells, Cultured | 1 | 2017 | 4006 | 0.020 |
Why?
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2011 | 940 | 0.020 |
Why?
| Linear Models | 1 | 2011 | 816 | 0.020 |
Why?
| Overweight | 1 | 2013 | 522 | 0.020 |
Why?
| Motor Activity | 1 | 2013 | 667 | 0.020 |
Why?
| Hydrogen-Ion Concentration | 1 | 2009 | 541 | 0.020 |
Why?
| Geography | 1 | 2008 | 186 | 0.020 |
Why?
| Colorado | 1 | 2018 | 4369 | 0.020 |
Why?
| Diagnostic Equipment | 1 | 2007 | 3 | 0.020 |
Why?
| Helicobacter Infections | 1 | 2007 | 28 | 0.020 |
Why?
| Selenium | 1 | 2007 | 36 | 0.020 |
Why?
| Helicobacter pylori | 1 | 2007 | 37 | 0.020 |
Why?
| Fraud | 1 | 2007 | 9 | 0.020 |
Why?
| Electrocoagulation | 1 | 2007 | 38 | 0.020 |
Why?
| Gastric Mucosa | 1 | 2007 | 50 | 0.020 |
Why?
| Laser Coagulation | 1 | 2007 | 57 | 0.020 |
Why?
| Quality Control | 1 | 2007 | 156 | 0.020 |
Why?
| Mice, Inbred C57BL | 1 | 2017 | 5268 | 0.020 |
Why?
| Capillaries | 1 | 2007 | 91 | 0.020 |
Why?
| Risk Management | 1 | 2007 | 85 | 0.020 |
Why?
| Immunohistochemistry | 1 | 2011 | 1663 | 0.020 |
Why?
| Leukocyte Count | 1 | 2007 | 325 | 0.020 |
Why?
| Image Processing, Computer-Assisted | 1 | 2009 | 734 | 0.010 |
Why?
| Diagnostic Imaging | 1 | 2007 | 329 | 0.010 |
Why?
| Health Policy | 1 | 2007 | 351 | 0.010 |
Why?
| Infant | 1 | 2018 | 8912 | 0.010 |
Why?
| Monocytes | 1 | 2007 | 546 | 0.010 |
Why?
| Antineoplastic Agents | 1 | 2014 | 2041 | 0.010 |
Why?
| Socioeconomic Factors | 1 | 2007 | 1211 | 0.010 |
Why?
| Comorbidity | 1 | 2007 | 1537 | 0.010 |
Why?
| Gene Expression Regulation | 1 | 2011 | 2508 | 0.010 |
Why?
| Neutrophils | 1 | 2007 | 1192 | 0.010 |
Why?
| Mice | 1 | 2017 | 16574 | 0.010 |
Why?
| Smoking | 1 | 2007 | 1459 | 0.010 |
Why?
| Diet | 1 | 2007 | 1198 | 0.010 |
Why?
|
|
Wani's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|